Cas:93138-61-5 (1-benzylpyrrolidin-3-yl)methanamine manufacturer & supplier

Chemical Name:(1-benzylpyrrolidin-3-yl)methanamine

CAS.NO:93138-61-5

Synonyms:1-(1-Benzyl-3-pyrrolidinyl)methanamine;MFCD06411056;3-Pyrrolidinemethanamine, 1-(phenylmethyl)-;(1-benzylpyrrolidin-3-yl)methanamine;1-(1-benzylpyrrolidin-3-yl)methanamine

Molecular Formula:C₁₂H₁₈N₂

Molecular Weight:190.285

HS Code:2933990090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:284.3±13.0 °C at 760 mmHg

Density:1.0±0.1 g/cm3

Index of Refraction:1.563

PSA:29.26000

Exact Mass:190.147003

LogP:1.20

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1-(1-Benzyl-3-pyrrolidinyl)methanamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-(1-benzylpyrrolidin-3-yl)methanamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-(1-benzylpyrrolidin-3-yl)methanamine Use and application,1-(1-benzylpyrrolidin-3-yl)methanamine technical grade,usp/ep/jp grade.

Related News: In 2016, in order to promote the innovative development, transformation and upgrading of the pharmaceutical industry, the Development and Reform Commission led the compilation of the Guiding Opinions on Promoting the Healthy Development of the Pharmaceutical Industry, which put forward requirements for all aspects of the medical industry and specifically proposed support for the field of chemical raw materials. . (1-benzylpyrrolidin-3-yl)methanamine manufacturer Villages and cities in China have resorted to flying drones with speakers to patrol streets and scold people not wearing masks in public amid the coronavirus outbreak, according to Chinese state media. (1-benzylpyrrolidin-3-yl)methanamine supplier Myelodysplastic syndromes (MDS) are conditions that can occur when the blood-forming cells in the bone marrow become dysfunctional and thus produce an inadequate number of circulating blood cells. (1-benzylpyrrolidin-3-yl)methanamine vendor At the same time, experts said that API companies need to increase investment in environmental protection, carry out industrial upgrades, improve processes, improve pollution treatment capabilities, and then achieve sustainable development in the future, and seize structural opportunities. (1-benzylpyrrolidin-3-yl)methanamine factory In 2016, in order to promote the innovative development, transformation and upgrading of the pharmaceutical industry, the Development and Reform Commission led the compilation of the Guiding Opinions on Promoting the Healthy Development of the Pharmaceutical Industry, which put forward requirements for all aspects of the medical industry and specifically proposed support for the field of chemical raw materials. .